Home > Financial Ratios > HIKAL

HIKAL
Core EBITDA Growth

    Back to All Ratios
HIKAL is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

HIKAL Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 23.712.67-24.025.3618.42

What is the latest Core EBITDA Growth ratio of HIKAL ?

The latest Core EBITDA Growth ratio of HIKAL is 23.71 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202523.71
Mar20242.67
Mar2023-24.02
Mar20225.36
Mar202118.42

How is Core EBITDA Growth of HIKAL Trending?

Years Core EBITDA Growth % Change
Mar2025 23.71
788.01
Mar2024 2.67
Positive
Mar2023 -24.02
Negative
Mar2022 5.36
-70.90
Mar2021 18.42 -

Other Financial Ratios of HIKAL


Compare Core EBITDA Growth ratio of peers of HIKAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HIKAL ₹2,630.6 Cr 15.7% 0.9% -42.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


HIKAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HIKAL

15.7%

0.9%

-42.5%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses